Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03046914
Recruitment Status : Unknown
Verified February 2017 by Heung-Woo Park, Seoul National University Hospital.
Recruitment status was:  Recruiting
First Posted : February 8, 2017
Last Update Posted : February 8, 2017
Sponsor:
Collaborator:
Ministry of Food and Drug Safety, Korea
Information provided by (Responsible Party):
Heung-Woo Park, Seoul National University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 30, 2017
Estimated Study Completion Date : November 30, 2017